Skip to content
★ Sign in to follow
IP

Immtech Pharmaceuticals, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by LEE LEVI HONG KAYE, was filed 07 Aug 2006.

Immtech Pharmaceuticals, Inc.: what insiders have been doing

This page follows insider dealings at Immtech Pharmaceuticals, Inc. as filed with SEC (Form 4). The past year has been quiet: not a single insider filing for Immtech Pharmaceuticals, Inc. The previous disclosure was published on 23 January 2008.

Since 2006, the database holds 1 purchase and 2 sales by insiders of the company.

Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
24
Thresholds
n/a
Buy Volume
€776
1 ops. · all time
Sell Volume
€26,408
2 ops. · all time

Financial data

· cache

Last declaration on 23 January 2008
Declarations24 total
  • ▼
    DirectorExecutives
    19,350 USD0SEC
    9,000 shares@ US$2.15Common Stock, $0.01 par valueSEC:0001116679-08-000221:0
  • ▼
    DirectorExecutives
    19,518 USD0SEC
    9,078 shares@ US$2.15Common Stock, $0.01 par valueSEC:0001116679-08-000221:1
  • ◆
    Chairman, President and CEOExecutives
    2,479 USD0SEC
    972 shares@ US$2.55Common Stock, par value $0.01SEC:0001116679-07-002983:0
  • ◆
    Chairman, President and CEOExecutives
    64,700 USD0SEC
    10,000 shares@ US$6.47Common Stock, par value $0.01SEC:0001116679-07-002983:1
  • ◆
    Exec. Director & Board MemberExecutives
    14,173 USD0SEC
    2,312 shares@ US$6.13Common Stock, $0.01 par valueSEC:0001116679-07-002581:0
  • ●
    Chairman, President and CEOExecutives
    2,692 USD0SEC
    342 shares@ US$7.87Common Stock, $0.01 par valueSEC:0001116679-07-001434:0
  • ●
    Chairman, President and CEOExecutives
    6,508 USD0SEC
    827 shares@ US$7.87Common Stock, $0.01 par valueSEC:0001116679-07-001434:1
  • ●
    Chairman, President and CEOExecutives
    2,703 USD0SEC
    510 shares@ US$5.30Common Stock, $0.01 par valueSEC:0001116679-07-001434:2
  • ●
    Chairman, President and CEOExecutives
    11,273 USD0SEC
    2,127 shares@ US$5.30Common Stock, $0.01 par valueSEC:0001116679-07-001434:3
  • ●
    Chairman, President and CEOExecutives
    2,694 USD0SEC
    410 shares@ US$6.57Common Stock, $0.01 par valueSEC:0001116679-07-001434:4
  • ●
    Chairman, President and CEOExecutives
    11,215 USD0SEC
    1,707 shares@ US$6.57Common Stock, $0.01 par valueSEC:0001116679-07-001434:5
  • ●
    Exec. Director & Board MemberExecutives
    0SEC
    3,583 shares0Common Stock, $0.01 par valueSEC:0001116679-07-001432:2
  • ◆
    DirectorExecutives
    36,000 USD0SEC
    6,000 shares@ US$6.00Common Stock, $0.01 par valueSEC:0001116679-07-000468:0
  • ◆
    Treasurer, Secretary and CFOExecutives
    3,000 USD0SEC
    500 shares@ US$6.00Common Stock, $0.01 par valueSEC:0001116679-07-000464:0
  • ◆
    Chairman, President and CEOExecutives
    24,000 USD0SEC
    4,000 shares@ US$6.00Common Stock, $0.01 par valueSEC:0001116679-07-000466:0
  • ◇
    DirectorExecutives
    17,850 USD0SEC
    7,000 shares@ US$2.55Common Stock, $0.01 par valueSEC:0001116679-07-000130:0
  • ◇
    DirectorExecutives
    104,500 USD0SEC
    22,000 shares@ US$4.75Common Stock, $0.01 par valueSEC:0001116679-06-002792:0
  • ◆
    DirectorExecutives
    104,503 USD0SEC
    12,338 shares@ US$8.47Common Stock, $0.01 par valueSEC:0001116679-06-002792:1
  • ◇
    DirectorExecutives
    33,250 USD0SEC
    7,000 shares@ US$4.75Common Stock, $0.01 par valueSEC:0001116679-06-002790:0
  • ◆
    DirectorExecutives
    33,253 USD0SEC
    3,926 shares@ US$8.47Common Stock, $0.01 par valueSEC:0001116679-06-002790:1
  • ▲
    DirectorExecutives
    1,000 USD0SEC
    200 shares@ US$5.00Common Stock, $0.01 par valueSEC:0000914121-06-002542:0
    Canonical exit: 1 Nov 2006 (T+90)
  • ●
    President and CEOExecutives
    30,000 USD0SEC
    5,000 shares@ US$6.00Common Stock, $0.01 par valueSEC:0000914121-06-002508:0
  • ●
    DirectorExecutives
    0SEC
    13,690 shares0Common Stock, $0.01 par valueSEC:0000914121-06-002354:0
  • ◆
    Executives
    36,750 USD0SEC
    5,000 shares@ US$7.35Common StockSEC:0000914121-06-001280:0

24 of 24 declarations

About Immtech Pharmaceuticals, Inc.

Immtech Pharmaceuticals, Inc. is a company focused on developing innovative pharmaceutical treatments. It specializes in solutions for infectious diseases and health-related disorders.